Skip to main content

Medicina previsões e probabilidades

·
A receita da Johnson & Johnson (JNJ) Q2 Innovation Medicine estará acima de __?

A receita da Johnson & Johnson (JNJ) Q2 Innovation Medicine estará acima de __?

53%

US$16,2 bilhões

$8.6K Vol.

$2.2K Liq.

Ends em 13 dias

A FDA aprova o adesivo semanal de baixa dose de estrogênio da Viatris?

A FDA aprova o adesivo semanal de baixa dose de estrogênio da Viatris?

45%

$218 Vol.

$418 Liq.

Ends em 28 dias

A FDA aprova o Atacicept da Vera Therapeutics?

A FDA aprova o Atacicept da Vera Therapeutics?

75%

$354 Vol.

$140 Liq.

Ends em 5 dias

FDA aprova transferência de tecnologia Arcalyst?

FDA aprova transferência de tecnologia Arcalyst?

14%

$5.7K Vol.

$240 Liq.

Ends há 13 dias

A FDA aprova o ONS-5010 da Outlook Therapeutics?

A FDA aprova o ONS-5010 da Outlook Therapeutics?

67%

$60 Vol.

$293 Liq.

Ends em 27 dias

A FDA aprova o Autoinjetor FUROSCIX ReadyFlow da MannKind?

A FDA aprova o Autoinjetor FUROSCIX ReadyFlow da MannKind?

80%

$175 Vol.

$95 Liq.

Ends em 24 dias

Bryan Johnson fará sexo novamente até 30 de junho?

Bryan Johnson fará sexo novamente até 30 de junho?

14%

31 de julho

$1.7K Vol.

$530 Liq.

1

Ends em 29 dias

A FDA aprova a Centanafadina da Otsuka?

A FDA aprova a Centanafadina da Otsuka?

92%

$22 Vol.

$123 Liq.

Ends em 22 dias

FDA aprova Rivoceranibe + camrelizumabe da Elevar Therapeutics?

FDA aprova Rivoceranibe + camrelizumabe da Elevar Therapeutics?

59%

$20 Vol.

$113 Liq.

Ends em 21 dias

FDA approves Celcuity's Gedatolisib?

FDA approves Celcuity's Gedatolisib?

70%

$0 Vol.

$138 Liq.

Ends em 15 dias

FDA aprova Sarclisa Subcutânea da Sanofi?

FDA aprova Sarclisa Subcutânea da Sanofi?

59%

$0 Vol.

$117 Liq.

Ends em 21 dias

Frequently Asked Questions

Polymarket is the world’s largest prediction market, where you can stay informed and profit from your knowledge by trading on things related to breaking news, politics, sports, elections, crypto, finance, tech, culture, including topics like Medicina.

Polymarket currently hosts 11 active markets for Medicina that lets you track or trade on predictions like “A receita da Johnson & Johnson (JNJ) Q2 Innovation Medicine estará acima de __?”. Whether you are tracking widely debated events or niche outcomes, the platform aggregates real-time odds based on over $17K in trading volume, providing a comprehensive view of fan and investor sentiment.

Each polymarket is a yes/no question, like “A FDA aprova o Atacicept da Vera Therapeutics?”. You buy shares in “yes” or “no” outcomes. Prices reflect crowd-sourced odds and probabilities. For example, if yes is at 30 cents, that’s a 30% chance. Markets resolve based on official results. For multi-outcome events, like “A receita da Johnson & Johnson (JNJ) Q2 Innovation Medicine estará acima de __?,” you simply trade on the specific outcome you think will win.

As of today, the most active market is “A receita da Johnson & Johnson (JNJ) Q2 Innovation Medicine estará acima de __?,” where the crowd is currently assigning a 53% chance to US$16,2 bilhões. These odds update in real-time as new information emerges and users trade, offering a dynamic snapshot of what the market believes will happen compared to traditional bookmaker odds.

It cuts through the noise. Unlike polls or punditry, Polymarket shows you real-time odds on Medicina predictions backed by financial conviction that are often faster and more accurate than experts or surveys. You get an unbiased view of what thousands of traders think will actually happen, often more accurate than polls. Plus, you can trade shares and potentially profit if your predictions are spot on.